LevelStock.com Newsletters Apr 18th, 2011
Good Morning Traders,
In my last newsletters, I presented to you where an Investment Agreement with Genetic Immunity & Insiders of PWRV are buying stock & filing Form 4's In the past some Investors totally overlook investment opportunities as insiders are buying and when they do realize it.. sometimes the stock price has already surged in price.
Power Of Dream Ventures "PWRV" Highlights
PWRV operates through it wholly owned Hungarian subsidiary, Vidatech. Through Vidatech, we aim to provide pro-active support for ideas, research, start-up and expansion-stage technology companies having rights to technologies or intellectual properties which we believe to be potentially commercially viable, by offering a range of services designed to encourage and protect the continuing development and eventual commercialization of those technologies.
PWRV focus is on technologies and technology companies based in the Republic of Hungary. We believe that the availability of technologies for purchase and license, coupled with the lack of sufficient investment capital for such technologies in Hungary, present us with an opportunity to technologies on terms and conditions which we deem advantageous.
PWRV strategy is to acquire majority interests in technologies through, among other things, direct investment in start-up and expansion stage technologies and technology companies; cooperative research and development agreements with such companies; direct licensing agreements; joint venture arrangements; or, direct acquisition of technologies and intellectual properties.
The announcement of our investment in Genetic Immunity is one of the most significant events in company history, commented Viktor Rozsnyay.
Top Highlights For Genetic Immunity "DermaVir"
(this is a must read)
***Genetic Immunity is an innovative biotech-nology company focusing on the development of nanomedicine based Therapeutic Vaccines against infectious diseases, cancer and other chronic conditions.
***Genetic Immunity's DermaVir is our candidate Therapeutic Vaccine designed for HIV-specific immune reconstitution. The Antiviral Mechanism of Action is based on inhibition of viral replication by cytotoxic killing of HIV-infected cells. Currently, there are no approved immune therapy or vaccine products on the market for HIV/AIDS.
***DermaVir, the world's first topical dendritic cell-targeting HIV therapeutic vaccine candidate, employs nanotechnology to boost the patient's own immune responses and to kill HIV-infected cells.
***Through the development of the Company's portfolio of vaccine candidates, Genetic Immunity's novel and innovative approach has demonstrated a consistent mechanism of action, safety and efficacy throughout the R&D pipeline from small animal preclinical models to the successful Phase II. Clinical Proof-of-Concept study of its most advanced vaccine candidate, DermaVir, developed for the treatment of HIV/AIDS.
***The goal of DermaVir immune boosting therapy is to decrease antiretroviral drug exposure while maintaining undetectable HIV-RNA levels and achieve a remission (functional cure) in HIV-infected patients.
For More Information on DermaVir, Visit Here.
****************************************************************
"Unlike traditional vaccines that prevent disease, therapeutic vaccines are given to people who are already infected to boost the body's immune response. To live a better and longer life, HIV-infected people boost their immune systems with vitamins, dietary supplements and herbs. We designed DermaVir to specifically boost their immune system to kill their HIV-infected cells and win the battle. Our Phase II trial provides the human proof of concept that immune boosting with DermaVir can reduce HIV viral load by killing the infected cells," said Julianna Lisziewicz, PhD and CEO of Genetic Immunity.
****************************************************************
Be ready at the opening bell this morning to watch PWRV trade. This company has been making headlines on the street over the last month as they have updated share holders with current events.
Stay Tuned. Happy Trading !
LevelStock.com
Follow us on Face Book FOLLOW US ON TWITTER
________________________________________________________________________________
This a paid advertisement. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Full Disclaimer can be read at Levelstock.com. We LevelStock.com is not a registered or licensed broker, broker dealer, market maker,investment advisor, analyst or underwriter. Nor are any of its officers, affiliates, owners or employees. Please consult a registered “certified” broker before purchasing, holding or selling any securities viewed on our site or emails. We reserve the right to buy and sell any stock “securities” profiled on this web site or in its newsletter at any given time. Stocks, companies, content material profiled by LevelStock.com is only for informational purposes, reference purposes only and is not recommendations to buy, sell or hold in these securities and does not provide an analysis of the financial position of the company. Our profiles, content material are compiled from publicly available sources that are accessible by the public from the internet. We take no responsibility for verifying the accuracy of such information and make no representation that such information is accurate or complete. Rule 17B requires disclosure of payment for investor relations. Rule 17B requires disclosure of payment for investor relations. LevelStock.com has been compensated ten thousand dollars by a third party for a one week advertisement for Power of the Dream Ventures, Inc. Release of Liability: Through use of this website viewing or using you agree to hold LevelStock.com, its officers, affiliates,operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur.
|
Email
Print
Digg
Del.icio.us
Reddit
Slashdot
Technorati
Newsvine
StumbleUpon
Google
Yahoo!
